Publication

Byline

Location

US Patent Issued to Dana-Farber Cancer Institute on Aug. 18 for "Potent and selective irreversible inhibitors of IRAK1" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,607, issued on Aug. 18, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "Potent and selective irreversible inhibitors of IRAK1"... और पढ़ें


US Patent Issued to University of Rochester, Ann & Robert H. Lurie Children's Hospital of Chicago on Aug. 18 for "4-amino pyrimidine compounds for the treatment of cancer" (New York, Illinois, Wisconsin Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,608, issued on Aug. 18, was assigned to University of Rochester (Rochester, N.Y.) and Ann & Robert H. Lurie Children's Hospital of Chicago (... और पढ़ें


US Patent Issued to Karyopharm Therapeutics on Aug. 18 for "Crystalline form of Selinexor" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,609, issued on Aug. 18, was assigned to Karyopharm Therapeutics Inc. (Newton, Mass.). "Crystalline form of Selinexor" was invented by Sean ... और पढ़ें


US Patent Issued to SHANGHAI ZHIMENG BIOPHARMA on Aug. 18 for "Preparation method for hepatitis B virus nucleocapsid inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,610, issued on Aug. 18, was assigned to SHANGHAI ZHIMENG BIOPHARMA INC. (Shanghai). "Preparation method for hepatitis B virus nucleocapsid ... और पढ़ें


US Patent Issued to Syremis Therapeutics on Aug. 18 for "Salt forms of sabcomeline" (Israeli Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,611, issued on Aug. 18, was assigned to Syremis Therapeutics Ltd. (Petach Tikva, Israel). "Salt forms of sabcomeline" was invented by Anton... और पढ़ें


US Patent Issued to Genentech on Aug. 18 for "Pyrido-pyrimidinyl compounds and methods of use" (Chinese, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,612, issued on Aug. 18, was assigned to Genentech Inc. (South San Francisco, Calif.). "Pyrido-pyrimidinyl compounds and methods of use" was... और पढ़ें


US Patent Issued to TXINNO BIOSCIENCE on Aug. 18 for "Naphthyridinone derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,613, issued on Aug. 18, was assigned to TXINNO BIOSCIENCE INC. (Gyeonggi-Do, South Korea). "Naphthyridinone derivative having inhibitory ac... और पढ़ें


US Patent Issued to ASCLETIS PHARMA (CHINA) on Aug. 18 for "GLP-1R agonist and therapeutic method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,614, issued on Aug. 18, was assigned to ASCLETIS PHARMA (CHINA) Co. Ltd. (Hong Kong). "GLP-1R agonist and therapeutic method thereof" was i... और पढ़ें


US Patent Issued to LG CHEM on Aug. 18 for "Organic light emitting device" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,615, issued on Aug. 18, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Organic light emitting device" was invented by Seulchan Park (D... और पढ़ें


US Patent Issued to Halia Therapeutics on Aug. 18 for "NEK7 inhibitors" (Utah Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,616, issued on Aug. 18, was assigned to Halia Therapeutics Inc.. "NEK7 inhibitors" was invented by David James Bearss (Lehi, Utah), John Sa... और पढ़ें